Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Different Methods Compared for Norovirus Detection

By LabMedica International staff writers
Posted on 31 Aug 2011
Commercial molecular and immunological tests have been evaluated in their ability to detect noroviruses in stool samples. More...


Two polymerase chain reaction (PCR) assays and an enzyme-linked immunosorbent assay (ELISA) have been tested under clinical conditions to diagnose and distinguish genogroups of noroviral infections.

Clinical microbiologists at the University of Szeged (Hungary) examined 61 stool samples for noroviruses from patients with clinical symptoms of acute gastroenteritis: nausea, vomiting, and/or three or more loose stools in 24 hours. For Norovirus detection two PCR assays, The Argene Calici/Astrovirus Consensus kit and the Norovirus Primer and Probe Set RT-PCR, were used in combination with the IDEIA ELISA method. The latter kit is an enzyme immunoassay for the qualitative determination of noroviruses of genogroups I (GGI) and GGII in stool samples. The IDEIA Norovirus ELISA system (DakoCytomation; Ely, UK) utilizes wells coated with GGI- and GGII-specific monoclonal antibodies. It is a very simple, rapid, but labor-intensive method for simultaneous screening of a large number of samples.

The ELISA method takes approximately two hours to carry out. The Argene kit takes 36 hours to achieve a result, while the Norovirus Primer and Probe Set real time-PCR method takes about six hours. All three methods were 100% specific for noroviruses. The sensitivity of the three methods was as follows: IDEIA ELISA was 78.9%; the Argene kit (Argene; North Massapequa, NY, USA) was 92.8%; and the Norovirus Primer and Probe Set (Cepheid; Sunnyvale, CA, USA) was 91.2%. The PCR and ELISA systems detected 52 Norovirus-positive samples, only one of which belonged to genogroup I and all the others to genogroup II. Although the ELISA kit had a lower sensitivity compared to the PCR ones, it may be useful for large-scale testing. However, the authors suggested that ELISA-negative outbreaks should be retested by RT-PCR methods.

As noroviruses are uncultivable, in clinical practice, it is important to obtain results as soon as possible in order to minimize the spread of the virus within and between hospital units. The results of this study suggest that noroviruses, and predominantly genogroup II of the norovirus genera, play an important role in outbreaks and sporadic cases of acute gastroenteritis, not only in infants and young children, but also in adults. The study was published in August 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of Szeged
DakoCytomation
Cepheid





Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.